Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medinotec (MDNC) EBITDA (2022 - 2025)

Medinotec's EBITDA history spans 4 years, with the latest figure at $662887.0 for Q4 2025.

  • For Q4 2025, EBITDA rose 123.87% year-over-year to $662887.0; the TTM value through Nov 2025 reached $2.6 million, up 241.79%, while the annual FY2025 figure was $2.1 million, 640.95% up from the prior year.
  • EBITDA reached $662887.0 in Q4 2025 per MDNC's latest filing, up from $359538.0 in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $1.4 million in Q1 2025 to a low of -$491911.0 in Q4 2023.
  • Average EBITDA over 4 years is $152266.8, with a median of $74971.5 recorded in 2023.
  • Peak YoY movement for EBITDA: plummeted 907.81% in 2023, then skyrocketed 1471.93% in 2025.
  • A 4-year view of EBITDA shows it stood at -$48810.0 in 2022, then tumbled by 907.81% to -$491911.0 in 2023, then surged by 160.2% to $296107.0 in 2024, then skyrocketed by 123.87% to $662887.0 in 2025.
  • Per Business Quant, the three most recent readings for MDNC's EBITDA are $662887.0 (Q4 2025), $359538.0 (Q3 2025), and $97993.0 (Q2 2025).